Jim Cramer’s 11 Stock Calls Including Marvell and Trane, and Caution About Overhyped AI Stocks
In this article, we will look at Jim Cramer’s Mad Money stock calls as he urged investors to exercise caution when it comes to red-hot AI stocks.
Design Therapeutics Inc. (DSGN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | SR One Capital Simeon George | 6,526,476 | $69,441,704 | 7.59% | |
| 2. | RA Capital Management Peter Kolchinsky | 2,972,973 | $31,632,433 | +104% | 0.34% |
| 3. | Point72 Asset Management Steve Cohen | 2,722,754 | $28,970,103 | -50% | 0.04% |
| 4. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,585,978 | $27,514,806 | +16% | 0.16% |
| 5. | Logos Capital Arsani William | 1,950,000 | $20,748,000 | -22% | 1.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.74 | 17,809 | $66,605.66 | 26,965 | 2024-03-25 | Filing | |
| $3.62 | 9,156 | $33,132.82 | 9,156 | 2024-03-22 | Filing | |
| $3.74 | 1,300 | $4,865.77 | 1,300 | 2024-03-25 | Filing | |
| $2.35 | 21,000 | $49,287.00 | 133,024 | 2023-09-29 | Filing | |
| $20.00 | 700,000 | $14,000,000.00 | 700,000 | 2021-03-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.25 | 217,627 | $1,142,541.75 | 1,000,000 | 2025-08-13 | Filing | |
| $5.25 | 345,000 | $1,811,250.00 | 2,655,000 | 2025-08-13 | Filing | |
| $6.27 | 3,806 | $23,863.62 | 20,000 | 2024-12-18 | Filing | |
| $4.25 | 814,874 | $3,463,214.50 | 0 | 2024-08-09 | Filing | |
| $18.63 | 1,455 | $27,105.49 | 4,129,950 | 2022-03-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,133,764 | $22,703,253 | 0% | |
| 2. | 1,349,850 | $14,362,404 | 0% | |
| 3. | 798,411 | $8,495,094 | 0% | |
| 4. | 692,518 | $7,370,662 | 0% | |
| 5. | 659,575 | $7,017,878 | 0% |
News See All
Design Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call Transcript
Design Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.32.
Hedge Fund and Insider Trading News: TimesSquare Capital Management, Hunting Hill Global Capital, Coinbase Global Inc (COIN), Design Therapeutics, Inc. (DSGN), and More
TimesSquare Capital Management, an equity investment management company, released its “U.S. Concentrated Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here.
Hedge Fund and Insider Trading News: Kyle Bass, Phase 2 Partners, Viking Global Investors, Elliott Management, Oasis Management, Third Point LLC, Origo Fonder, Design Therapeutics Inc (DSGN), and More
Hayman Capital Management founder and CIO Kyle Bass joined "Mornings with Maria," Wednesday and warned that Wall Street is "funding" Russia’s war machine.
Hedge Fund and Insider Trading News: Engine No. 1, Renaissance Technologies, Glenview Capital, Morgan Creek Capital, Ree Automotive Holding Inc (REE), Xcel Energy Inc (XEL), and More
Activist firm Engine No. 1 after winning three board seats at Exxon is meeting with other oil companies in its climate change fight, a source familiar told CNBC’s David Faber.